Partially exhausted CD8+ T cells are associated with clinically beneficial response to Teplizumab in new onset type I diabetes
Ontology highlight
ABSTRACT: Partially exhausted CD8+ T cells are associated with clinically beneficial response to Teplizumab in new onset type I diabetes
PROVIDER: PRJNA338813 | ENA |
REPOSITORIES: ENA
ACCESS DATA